Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Sorrento Therapeutics (SRNEQ)
OTHER OTC:SRNEQ
Sorrento Therapeutics (SRNEQ) Stock Price & Analysis
5,267 Followers
SRNEQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.16 - $3.09
Previous Close$0.32
Volume1.15M
Average Volume (3M)2.52M
Market Cap
$174.65M
Enterprise Value$291.95M
Total Cash (Recent Filing)$50.32M
Total Debt (Recent Filing)$169.55M
Price to Earnings (P/E)-0.2
Beta2.03
Next Earnings
Aug 10, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.43
Shares Outstanding547,880,267
10 Day Avg. Volume1,427,414
30 Day Avg. Volume2,521,947
Standard Deviation0.36
R-Squared0.10
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)3.90
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.30
Enterprise Value/Gross Profit9.84
Enterprise Value/Ebitda-0.46
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SRNEQ FAQ
What was Sorrento Therapeutics’s price range in the past 12 months?
Sorrento Therapeutics lowest stock price was $0.16 and its highest was $3.09 in the past 12 months.
What is Sorrento Therapeutics’s market cap?
Currently, no data Available
When is Sorrento Therapeutics’s upcoming earnings report date?
Sorrento Therapeutics’s upcoming earnings report date is Aug 10, 2023 which is in 64 days.
How were Sorrento Therapeutics’s earnings last quarter?
Sorrento Therapeutics released its earnings results on May 15, 2023. The company reported -$0.257 earnings per share for the quarter, missing the consensus estimate of -$0.16 by -$0.097.
Is Sorrento Therapeutics overvalued?
According to Wall Street analysts Sorrento Therapeutics’s price is currently Overvalued.
Does Sorrento Therapeutics pay dividends?
Sorrento Therapeutics does not currently pay dividends.
What is Sorrento Therapeutics’s EPS estimate?
Sorrento Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sorrento Therapeutics have?
Sorrento Therapeutics has 551,281,100 shares outstanding.
What happened to Sorrento Therapeutics’s price movement after its last earnings report?
Sorrento Therapeutics reported an EPS of -$0.257 in its last earnings report, missing expectations of -$0.16. Following the earnings report the stock price went up 20%.
Which hedge fund is a major shareholder of Sorrento Therapeutics?
Among the largest hedge funds holding Sorrento Therapeutics’s share is Graham Capital Management, L.P.. It holds Sorrento Therapeutics’s shares valued at N/A.
---
Sorrento Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
SRNEQ Sentiment 67%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 13.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $15.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-81.52%
12-Months-Change
Fundamentals
Return on Equity
-1329.41%
Trailing 12-Months
Asset Growth
-46.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Sorrento Therapeutics
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.
---
Top 5 ETFs holding SRNEQ
Fidelity Nasdaq Composite Index ETF
$4.98K
Up to five ETFs with an Outperform Smart Score that hold SRNEQ. The ETFs are listed according to market value of SRNEQ within the ETF
---
---